Detalhe da pesquisa
1.
Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors.
BMC Cancer
; 21(1): 1304, 2021 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34872526
2.
Neuropathic pain prevalence and risk factors in head and neck cancer survivors.
Head Neck
; 44(12): 2820-2833, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129114